Corporate Action2 Min Read InvestyWise NewsonNovember 13, 2025 NBCC India Board Approves Interim Dividend and Reviews Financial Results for Q2 2026 NBCC India’s Board of Directors approved a ₹0.21 per share interim dividend for the financial year 2025-26, alongside reviewing the…
Insider Trading / SAST1 Min Read InvestyWise NewsonNovember 13, 2025 CM Airtime Promotion Acquisition of Additional Shares in Chambal Fertilisers CM Airtime Promotion LLP has increased its stake in Chambal Fertilisers & Chemicals Ltd. The company acquired 10,000 equity shares on…
Corporate Action2 Min Read InvestyWise NewsonNovember 13, 2025 NBCC (India) Board Approves Interim Dividend, Reviews Financial Results for Q2 2026 NBCC (India) Limited announced the approval of a ₹0.21 per share interim dividend (21%) for the financial year 2025-26. The decision was made…
Company Results1 Min Read InvestyWise NewsonNovember 13, 2025 Page Industries Interim Dividend Declared at ₹125 Per Share; Approves Unaudited Q2 Results Page Industries has announced an interim dividend of ₹125 per equity share. This announcement was made alongside the approval of the unaudited…
Board Meeting1 Min Read InvestyWise NewsonNovember 13, 2025 NBCC India Declares Interim Dividend, Reports Q2 FY26 Results NBCC India announced its Q2 FY26 results, reporting revenue from operations of ₹2,91,019.80 Lakh and a net profit of ₹15,668.72 Lakh. The…
Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Q2 FY26 Earnings Show Strong Growth in Formulations Granules India reported a robust Q2 FY26, driven by formulations growth in North America and Europe. Sales increased, with EBITDA rising due…
Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Q2 FY26 Revenue Up 34% YoY, PAT Rises 34% Granules India announced a strong financial performance for the second quarter of fiscal year 2026 (Jul-Sep). Revenue from operations…
Company Update2 Min Read InvestyWise NewsonNovember 13, 2025 Alkem Laboratories Q2 FY26 Revenue Up 17%, EBITDA Surges 22% Alkem Laboratories announced a strong performance in Q2 FY26, with revenue increasing by 17.2% to ₹40,010 Mn. The company’s EBITDA grew…
Company Update1 Min Read InvestyWise NewsonNovember 13, 2025 Zydus Lifesciences Receives USFDA Approval for Diroximel Fumarate Capsules Zydus Lifesciences has secured tentative approval from the USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg. These capsules are…
Board Meeting2 Min Read InvestyWise NewsonNovember 13, 2025 Granules India Acquisition and Financial Results Announcement Granules India has announced the approval of its unaudited financial results for Q2 FY26, the acquisition of optus 1039, GmBH in Germany, and…